Bisphosphonates in the treatment of patients with lung cancer and metastatic bone disease: a systematic review and meta-analysis
MA Lopez-Olivo, NA Shah, G Pratt, JM Risser… - Supportive Care in …, 2012 - Springer
Purpose Bisphosphonates are known to prevent skeletal-related events (SREs) in advanced
breast cancer, prostate cancer, and multiple myeloma. This systematic review assessed the …
breast cancer, prostate cancer, and multiple myeloma. This systematic review assessed the …
Management of metastatic bone disease algorithms for diagnostics and treatment
CF Jehn, IJ Diel, F Overkamp, A Kurth… - Anticancer …, 2016 - ar.iiarjournals.org
Background: Bone is a frequent site of metastases in advanced cancer and is associated
with significant skeletal morbidity. Current treatment options are aimed at preserving and …
with significant skeletal morbidity. Current treatment options are aimed at preserving and …
Early inhibitory effects of zoledronic acid in tooth extraction sockets in dogs are negated by recombinant human bone morphogenetic protein
DA Gerard, ER Carlson, JE Gotcher… - Journal of Oral and …, 2014 - Elsevier
Purpose This study was conducted with 2 purposes. The first was to determine the effect of a
single dose of zoledronic acid (ZA) on the healing of a tooth extraction socket in dogs. The …
single dose of zoledronic acid (ZA) on the healing of a tooth extraction socket in dogs. The …
Denosumab versus bisphosphonates for the treatment of bone metastases from solid tumors: a systematic review
Background Bone metastases are highly prevalent in breast, prostate, lung and colon
cancers. Their symptoms negatively affect quality of life and functionality and optimal …
cancers. Their symptoms negatively affect quality of life and functionality and optimal …
The economics of abiraterone acetate for castration-resistant prostate cancer
A Dellis, AG Papatsoris - Expert review of pharmacoeconomics & …, 2014 - Taylor & Francis
Abiraterone acetate is an oral medication that has recently been granted approval for the
treatment of metastatic castration resistant prostate cancer (mCRPC) prior and/or after …
treatment of metastatic castration resistant prostate cancer (mCRPC) prior and/or after …
Canadian health care institution resource utilization resulting from skeletal-related events
MJ Habib, T Merali, A Mills, V Uon - Hospital Practice, 2014 - Taylor & Francis
Purpose: We describe the types of major institution health care resources consumed as a
result of skeletal-related events (SREs)[ie, pathological fracture, bone surgery, radiation to …
result of skeletal-related events (SREs)[ie, pathological fracture, bone surgery, radiation to …
BONE TARGETING AGENTS IN PREVENTION OF SKELETAL-RELATED EVENTS IN METASTATIC CANCERS OF SOLID TUMOURS: AN ECONOMIC EVALUATION
HF Kamaruzaman, A Shaharudin… - Proceedings of the …, 2019 - tiikmpublishing.com
Skeletal related events (SREs) are skeletal complications from bone metastases such as
spinal cord compression, pathological fracture, palliative radiation to the bone and bone …
spinal cord compression, pathological fracture, palliative radiation to the bone and bone …
Interdisziplinäre Therapie von Knochenmetastasen
J Fakler, T Todenhöfer, M Müller, AA Kurth… - Fortbildung Osteologie …, 2018 - Springer
Radiomorphologisch imponieren sie osteolytisch, osteoblastisch oder als gemischte Form
(Buckwalter u. Brandser 1997). Tumorzellen, die sich im Knochenmark absiedeln, sind in …
(Buckwalter u. Brandser 1997). Tumorzellen, die sich im Knochenmark absiedeln, sind in …
Interdisziplinäre Therapie von Knochenmetastasen
R von Knochenmetastasen - Fortbildung Osteologie 4, 2018 - books.google.com
Radiomorphologisch imponieren sie osteolytisch, osteoblastisch oder als gemischte Form
(Buckwalter u. Brandser 1997). Tumorzellen, die sich im Knochenmark absiedeln, sind in …
(Buckwalter u. Brandser 1997). Tumorzellen, die sich im Knochenmark absiedeln, sind in …